nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Hallucination—Dexamethasone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Gadodiamide—Hallucination—Betamethasone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Gadodiamide—Ataxia—Methotrexate—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Gadodiamide—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Gadodiamide—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Gadodiamide—Visual impairment—Betamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Gadodiamide—Visual impairment—Dexamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Gadodiamide—Myocardial infarction—Prednisone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Gadodiamide—Malaise—Prednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Gadodiamide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Gadodiamide—Syncope—Prednisolone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Gadodiamide—Convulsion—Prednisolone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Gadodiamide—Arrhythmia—Betamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Gadodiamide—Arrhythmia—Dexamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Gadodiamide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Gadodiamide—Discomfort—Prednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Gadodiamide—Hallucination—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Gadodiamide—Malaise—Triamcinolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Gadodiamide—Malaise—Methylprednisolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Gadodiamide—Syncope—Triamcinolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Gadodiamide—Syncope—Methylprednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Gadodiamide—Oedema—Prednisolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Gadodiamide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Gadodiamide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Gadodiamide—Shock—Prednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Gadodiamide—Convulsion—Triamcinolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Gadodiamide—Tachycardia—Prednisolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Gadodiamide—Convulsion—Methylprednisolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Gadodiamide—Myalgia—Triamcinolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Gadodiamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Gadodiamide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Gadodiamide—Anxiety—Methylprednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Gadodiamide—Flushing—Prednisone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Gadodiamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Gadodiamide—Discomfort—Triamcinolone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Gadodiamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Gadodiamide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Gadodiamide—Malaise—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Gadodiamide—Malaise—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Gadodiamide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Gadodiamide—Oedema—Triamcinolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Gadodiamide—Syncope—Dexamethasone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Gadodiamide—Syncope—Betamethasone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Gadodiamide—Arrhythmia—Prednisone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Gadodiamide—Infection—Triamcinolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Gadodiamide—Infection—Methylprednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Gadodiamide—Shock—Triamcinolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Gadodiamide—Shock—Methylprednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Gadodiamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Gadodiamide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Gadodiamide—Convulsion—Dexamethasone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Gadodiamide—Convulsion—Betamethasone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Gadodiamide—Myalgia—Dexamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Gadodiamide—Myalgia—Betamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Gadodiamide—Anxiety—Betamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Gadodiamide—Anxiety—Dexamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Gadodiamide—Discomfort—Betamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Gadodiamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Gadodiamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Gadodiamide—Pain—Prednisolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Gadodiamide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Gadodiamide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Gadodiamide—Oedema—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Gadodiamide—Oedema—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Gadodiamide—Infection—Dexamethasone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Gadodiamide—Infection—Betamethasone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Gadodiamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Gadodiamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Gadodiamide—Shock—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Gadodiamide—Shock—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Gadodiamide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Gadodiamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Gadodiamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Gadodiamide—Tachycardia—Dexamethasone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Gadodiamide—Tachycardia—Betamethasone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Gadodiamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Gadodiamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Gadodiamide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Gadodiamide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Gadodiamide—Malaise—Prednisone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Gadodiamide—Syncope—Prednisone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Gadodiamide—Urticaria—Prednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Gadodiamide—Fatigue—Triamcinolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Gadodiamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Gadodiamide—Pain—Triamcinolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Hypotension—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Gadodiamide—Hypotension—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Gadodiamide—Convulsion—Prednisone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Gadodiamide—Chills—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Gadodiamide—Myalgia—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Gadodiamide—Arthralgia—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Gadodiamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Gadodiamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Gadodiamide—Anxiety—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Gadodiamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Gadodiamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Gadodiamide—Discomfort—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Gadodiamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Gadodiamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Gadodiamide—Urticaria—Triamcinolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Gadodiamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Gadodiamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Gadodiamide—Oedema—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Gadodiamide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Gadodiamide—Infection—Prednisone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Gadodiamide—Fatigue—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Gadodiamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Gadodiamide—Shock—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Gadodiamide—Pain—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Gadodiamide—Pain—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Gadodiamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Gadodiamide—Tachycardia—Prednisone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Gadodiamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Gadodiamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Gadodiamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Gadodiamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Gadodiamide—Urticaria—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Gadodiamide—Urticaria—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Gadodiamide—Dizziness—Prednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Gadodiamide—Asthenia—Triamcinolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Gadodiamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Gadodiamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Gadodiamide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Gadodiamide—Abdominal pain—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Gadodiamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Gadodiamide—Pruritus—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Gadodiamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Gadodiamide—Dyspepsia—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Gadodiamide—Rash—Prednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Gadodiamide—Dermatitis—Prednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Gadodiamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Gadodiamide—Fatigue—Prednisone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Gadodiamide—Headache—Prednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Gadodiamide—Dizziness—Triamcinolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Gadodiamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Gadodiamide—Infection—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Gadodiamide—Asthenia—Betamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Gadodiamide—Asthenia—Dexamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Gadodiamide—Nausea—Prednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Gadodiamide—Pruritus—Betamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Gadodiamide—Pruritus—Dexamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Gadodiamide—Vomiting—Triamcinolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Gadodiamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Gadodiamide—Rash—Triamcinolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Gadodiamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Gadodiamide—Rash—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Gadodiamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Gadodiamide—Urticaria—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Gadodiamide—Headache—Triamcinolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadodiamide—Headache—Methylprednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadodiamide—Body temperature increased—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadodiamide—Abdominal pain—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Gadodiamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gadodiamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Gadodiamide—Dizziness—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Gadodiamide—Dizziness—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Gadodiamide—Nausea—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadodiamide—Nausea—Methylprednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Gadodiamide—Vomiting—Dexamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Gadodiamide—Vomiting—Betamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Gadodiamide—Rash—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadodiamide—Rash—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadodiamide—Dermatitis—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadodiamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Gadodiamide—Headache—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gadodiamide—Headache—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gadodiamide—Asthenia—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Gadodiamide—Pain—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Gadodiamide—Pruritus—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Gadodiamide—Diarrhoea—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Gadodiamide—Nausea—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Gadodiamide—Nausea—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Gadodiamide—Dizziness—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Gadodiamide—Vomiting—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Gadodiamide—Rash—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadodiamide—Dermatitis—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Gadodiamide—Headache—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Gadodiamide—Nausea—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Gadodiamide—Rash—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Gadodiamide—Headache—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
